Tajima Tetsuya, Zhang Wenming, Han Shuling, Reitsma Andrea, Harden James T, Fuentes Samuel, Sonehara Ayaka, Esquivel Carlos O, Martinez Olivia M, Krams Sheri M
Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, United States.
Stanford Immunology, Stanford University School of Medicine, Stanford, CA, United States.
Front Immunol. 2025 Jun 4;16:1584916. doi: 10.3389/fimmu.2025.1584916. eCollection 2025.
Vascularized Composite Allotransplantation (VCA) is an important therapeutic option for patients that incur debilitating injuries to the face or limbs. The complexity and immunogenicity of tissue types within VCA grafts pose unique challenges and necessitate the use of intensive immunosuppression; however, graft rejection remains a challenge in VCA.
Deep proteomic profiling and high dimensional analysis with cytometry time of flight were used to define the cell types and effector mechanisms elicited by VCA in BALB/c (H-2Kd) > C57BL/6 (H-2Kb) limb recipients. Spleen and cervical draining lymph nodes were collected post-transplant days 1, 3, 5, and 7 (n =4-6 mice/group/day). We identified dynamic, coordinated signatures in T cell and monocyte populations associated with VCA allograft rejection.
In comparison to syngeneic transplant recipients, allogeneic recipients exhibited significant alterations in the immune cell populations within secondary lymphoid tissues. These changes included very early expansion of double-negative TCRβ T cells, including IL-17A-producing γδ T cells, and patrolling monocytes. Subsequently, CD8+CD62L+ T cells and CD8+ effector/effector memory T cells (Teff/Tem), Ly6CCCR2CX3CR1 classical monocytes, CD4+ Teff/Tem, and CD8+CD25CCR7 Teff/Tem were increased by day 5. CD8+CD25CCR7 Teff/Tem with the highest expression of IFN-γ, perforin, and granzyme B were enriched by day 7.
High dimensional proteomic analysis reveals multiple innate and Teff/Tem subsets in acute rejection following VCA. In particular, IL-17A-producing γδ T cells and classical monocytes may be particularly important in initiating the alloimmune response in VCA recipients.
血管化复合组织异体移植(VCA)是面部或肢体遭受致残性损伤患者的重要治疗选择。VCA移植物中组织类型的复杂性和免疫原性带来了独特的挑战,需要使用强化免疫抑制;然而,移植物排斥仍是VCA面临的一项挑战。
采用深度蛋白质组学分析和飞行时间质谱流式细胞术进行高维分析,以确定BALB/c(H-2Kd)> C57BL/6(H-2Kb)肢体受者中VCA引发的细胞类型和效应机制。在移植后第1、3、5和7天收集脾脏和颈部引流淋巴结(每组每天n = 4 - 6只小鼠)。我们在与VCA同种异体移植物排斥相关的T细胞和单核细胞群体中鉴定出动态、协调的特征。
与同基因移植受者相比,异基因受者的二级淋巴组织内免疫细胞群体出现了显著变化。这些变化包括双阴性TCRβ T细胞(包括产生IL-17A的γδ T细胞)和巡逻单核细胞的极早期扩增。随后,到第5天时,CD8 + CD62L + T细胞、CD8 + 效应/效应记忆T细胞(Teff/Tem)、Ly6C高表达CCR2CX3CR1的经典单核细胞、CD4 + Teff/Tem以及CD8 + CD25 + CCR7 Teff/Tem增加。到第7天时,IFN-γ、穿孔素和颗粒酶B表达最高的CD8 + CD25 + CCR7 Teff/Tem富集。
高维蛋白质组分析揭示了VCA后急性排斥反应中的多个固有免疫和Teff/Tem亚群。特别是,产生IL-17A的γδ T细胞和经典单核细胞可能在启动VCA受者的同种免疫反应中尤为重要。